MedPath

Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Not Applicable
Recruiting
Conditions
Lung Transplantation
Interventions
Device: Lung uDCD Protocol
Registration Number
NCT06327945
Lead Sponsor
NYU Langone Health
Brief Summary

The study team developed an uncontrolled donation after circulatory death (uDCD) protocol that preserves lungs for just over 3 hours after death using positive end expiratory pressure (PEEP) and supplemental oxygen. The study will assess lung uDCD program safety by continuous review of operations/clinical records from each case activation and transplantation. Attrition outcomes include rates of initial and continued lung preservation, donation authorization, lung recovery, passing ex-vivo lung perfusion (EVLP) performance testing, and lung transplantation. Planned viability assessments also include macroscopic determination, radiology (X-ray), and fiber optic bronchoscopy before initiating EVLP. We expect \~50% of lungs assessed with EVLP will be transplanted to meet sustainability targets. Safety outcomes include the primary outcome, primary graft dysfunction (PGD) grade III at 72 hours, and secondarily survival one year after transplantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patients waiting for lung transplants
  • Willing to participate in the research study
Exclusion Criteria
  • Unable to be followed for 1 year after transplantation
  • Unable to provide written informed consent to participate in the research (or designate a surrogate)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lung uDCD ProtocolLung uDCD Protocol-
Primary Outcome Measures
NameTimeMethod
Incidence of Primary Graft Dysfunction (PDG) Grade III72 Hours Post-Transplant

PGD is measured 72 hours after transplantation and defined according to the International Society for Heart and Lung Transplantation (ISHLT) criteria: partial pressure of arterial oxygen divided by the fraction of inspired oxygen (Pa02/FI02) \< 200 mm Hg.

Secondary Outcome Measures
NameTimeMethod
Number of Participants who Required Normothermic Extracorporeal Membrane Oxygenation (nECMO)1 Year Post-Transplant
Incidence of Re-Transplantation1 Year Post-Transplant
Overall Survival1 Year Post-Transplant

Time from transplant to death due to any cause.

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath